Investigating the role of a specific protein in ovarian cancer

Role of protein kinase ADCK5 in ovarian cancer

NIH-funded research University of Maryland Baltimore County · NIH-10725728

This study is looking at how a protein called ADCK5 affects the growth of ovarian cancer and why some treatments might not work, with the goal of finding better ways to help patients with ovarian cancer live longer and healthier lives.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of Maryland Baltimore County NIH-funded
Lab location1 site (Baltimore, United States)
Project IDNIH-10725728 on NIH RePORTER

What this research studies

This research focuses on understanding how the protein kinase ADCK5 influences ovarian cancer progression and treatment resistance. By examining the genetic factors associated with ADCK5, researchers aim to identify new therapeutic targets that could improve treatment outcomes for patients with ovarian cancer. The study will analyze the relationship between ADCK5 expression and patient survival, particularly in those with specific genetic mutations. This could lead to more effective treatment strategies for patients facing this challenging disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are women diagnosed with ovarian cancer, especially those with p53 mutations.

Not a fit: Patients with early-stage ovarian cancer or those without p53 mutations may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that improve survival rates for ovarian cancer patients, particularly those with drug-resistant forms of the disease.

How similar studies have performed: Previous research has shown promising results in targeting genetic factors in cancer treatment, suggesting that this approach may yield beneficial outcomes.

Where this research is happening

Baltimore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions cancer drug resistanceAnti-Cancer AgentsCancer DrugNeoplastic Disease Chemotherapeutic Agentsanti-cancer drug
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.